KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $65.50 $80.00 Friday, 26th Apr 2024 AXSM stock ended at $71.71. This is 0.266% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $69.70 to a day high of $72.43.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Mar 23, 2023 $63.50 $65.56 $61.47 $62.01 747 358
Mar 22, 2023 $62.92 $64.85 $62.43 $62.96 637 013
Mar 21, 2023 $63.58 $64.63 $62.75 $62.88 1 029 579
Mar 20, 2023 $62.34 $63.62 $60.65 $63.20 675 349
Mar 17, 2023 $63.27 $63.66 $61.45 $62.74 1 049 350
Mar 16, 2023 $61.15 $64.05 $59.85 $63.24 670 827
Mar 15, 2023 $62.93 $63.25 $60.69 $61.93 523 739
Mar 14, 2023 $61.62 $63.88 $61.60 $63.37 816 292
Mar 13, 2023 $58.25 $62.78 $57.88 $60.86 1 309 611
Mar 10, 2023 $61.90 $62.98 $53.71 $58.39 3 263 146
Mar 09, 2023 $63.55 $64.06 $61.36 $61.97 665 900
Mar 08, 2023 $63.52 $63.83 $61.32 $63.56 553 044
Mar 07, 2023 $66.44 $66.62 $63.25 $63.50 650 537
Mar 06, 2023 $64.97 $66.34 $64.21 $66.32 667 600
Mar 03, 2023 $65.14 $66.31 $63.93 $65.28 628 433
Mar 02, 2023 $66.46 $66.49 $63.66 $65.32 741 159
Mar 01, 2023 $67.84 $70.75 $65.90 $66.89 1 133 156
Feb 28, 2023 $63.50 $70.41 $63.41 $68.19 1 857 678
Feb 27, 2023 $64.00 $65.98 $61.58 $64.08 1 608 101
Feb 24, 2023 $61.00 $62.22 $59.51 $61.05 1 092 192
Feb 23, 2023 $62.52 $62.70 $60.83 $61.93 827 173
Feb 22, 2023 $64.23 $65.02 $62.20 $62.61 663 828
Feb 21, 2023 $66.01 $66.95 $63.34 $63.46 628 505
Feb 17, 2023 $64.74 $67.59 $63.80 $66.62 855 162
Feb 16, 2023 $62.88 $65.38 $62.03 $64.03 750 350
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT